Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Aliment Pharmacol Ther ; 45(2): 300-309, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-27868216

RESUMEN

BACKGROUND: Conflicting results have been recently reported for the accuracy of the Endoscopic Reference Score (EREFS), an standardised endoscopic classification, to predict the histological activity of eosinophilic oesophagitis (EoE). AIM: To evaluate the accuracy of the EREFS to predict either histological or clinical activity of EoE. METHODS: Prospective multicentre study conducted in eight Spanish centres evaluating adult EoE patients, either naïve or after treatment. Symptoms were evaluated before upper endoscopy through the Dysphagia Symptom Score, whereas researchers scored the EREFS immediately after the endoscopic procedure, unaware of the histological outcome. RESULTS: One hundred and forty-five EoE patients undergoing 240 consecutive endoscopic procedures were included. Exudates (P = 0.03), furrows (P = 0.03) and a composite score of inflammatory signs (exudates, furrows and oedema) (P < 0.001) accurately predicted histological activity. Exudates were the only endoscopic sign showing a good correlation with histological outcome after therapy. Furrows and oedema persisted in 50% and 70% of patients despite histological remission. No endoscopic feature exceeded 70% accuracy to predict histological activity. Likewise, no endoscopic finding could adequately predict dysphagia severity. Crepe paper mucosa, diffuse exudates and severe rings correlated with higher symptom scores. CONCLUSIONS: Endoscopic findings assessed by the Endoscopic Reference Score did not correlate with histological or clinical disease activity in adult EoE patients. Only exudates correlated with peak eosinophil count and histological outcome, whereas furrows and oedema persisted in over half of patients despite histological remission.


Asunto(s)
Esofagitis Eosinofílica/patología , Gastroscopía , Adulto , Trastornos de Deglución/diagnóstico , Trastornos de Deglución/inmunología , Trastornos de Deglución/patología , Esofagitis Eosinofílica/diagnóstico , Esofagitis Eosinofílica/inmunología , Eosinófilos/inmunología , Esófago/inmunología , Esófago/patología , Femenino , Humanos , Recuento de Leucocitos , Masculino , Persona de Mediana Edad , Membrana Mucosa/inmunología , Membrana Mucosa/patología , Estudios Prospectivos , Valores de Referencia , Adulto Joven
2.
Aliment Pharmacol Ther ; 38(7): 752-60, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23980933

RESUMEN

BACKGROUND: Recently, the notion that smoking may adversely affect Crohn's disease (CD) outcomes has been challenged by the suggestion that the widespread use of immunosuppressants and anti-TNF drugs might offset the adverse effects of tobacco. AIM: To reassess the influence of tobacco smoking on disease phenotype and complications on a time-dependent analysis, taking into account the different therapeutic interventions. METHODS: We designed a retrospective cohort study of 3224 patients with Crohn's disease. The data were collected from the Spanish national inflammatory bowel disease registry (ENEIDA), including information regarding demographics, clinical characteristics, disease complications, therapeutic interventions and smoking status. Patients were classified as nonsmokers, smokers and former smokers, according to their present and past smoking habits. RESULTS: In the univariate analysis, smokers had more strictures (22.6% vs. 19.3%, P < 0.05) and less colonic involvement (7.2% vs. 10.9%, P < 0.05), and were more frequently under treatment with steroids (91.6% vs. 85.8%, P < 0.05), immunosuppressants (73.5% vs. 63.6% P < 0.05) or anti-TNF drugs (31.4% vs. 25.1%, P < 0.05) than nonsmokers. In the time-dependent multivariate analysis, smokers were found to have a significantly decreased survival free of stricturing disease (HR: 1.5, CI 95% 1.18-1.90) or perianal complications (HR: 1.50, CI 95% 1.01-1.46), and had a higher risk for requiring thiopurine therapy (HR: 1.20, CI 95% 1.05-1.30). CONCLUSION: These results suggest that, despite the widespread use of immunosuppressants and anti-TNF drugs, smokers with Crohn's disease still have a more severe disease course, with increased therapeutic requirements when compared with nonsmokers.


Asunto(s)
Enfermedad de Crohn/fisiopatología , Factores Inmunológicos/uso terapéutico , Inmunosupresores/uso terapéutico , Fumar/efectos adversos , Adulto , Antiinflamatorios/uso terapéutico , Estudios de Cohortes , Enfermedad de Crohn/tratamiento farmacológico , Progresión de la Enfermedad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Sistema de Registros , Estudios Retrospectivos , Riesgo , Índice de Severidad de la Enfermedad , España , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores
3.
Rev Esp Enferm Dig ; 104(10): 550-2, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23268636

RESUMEN

The growing endoscopic activity, both diagnostic and therapeutic, are also globally makes frequent endoscopic complications, perforation being one of the most serious. However, we also have more possibilities for endoscopic resolution of iatrogenic caused. We report the case of a sigmoid perforation during a colonoscopy that was resolved satisfactorily, avoiding surgery, by endoscopic closure with a nitinol clip Ovesco®.


Asunto(s)
Colon Sigmoide/lesiones , Colonoscopía/efectos adversos , Perforación Intestinal/etiología , Perforación Intestinal/terapia , Anciano de 80 o más Años , Femenino , Humanos , Enfermedad Iatrogénica , Perforación Intestinal/patología , Instrumentos Quirúrgicos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...